https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
PY
$790
$719
$107
$114
Sales Adjusted EBITDA
$0.42
$0.52
- 9% + 7% + 24%
Sales Adjusted EBITDA Adjusted EPS
15
Q4 2023 SEGMENT PERFORMANCE
16
CAI
$491
$459
Sales
$70
$84
SEM
$301
$260
Sales
$55
$49
- 7% - 14%+20% - 11%
Q4 EBITDA BRIDGE
17
$ millions
CAI:
Price / Mix 11
Deflation 14
SEM:
Price / Mix 4
Deflation 9
Net Price Benefit 38
Cost Reductions 13
Wage Inflation (8)
Other (2)
Q4 2023 $114
Adjusted
Q4 2022 $ 107
Demand (34) • Demand was down, but less than in previous
quarters, due to slowing pace of destocking
• Positive net price benefit:
o CAI – Pricing flat with favorable mix from
uptick in packaging and consumer end
markets and raw material deflation
o SEM - Pricing flat with favorable mix from
Composites and raw material deflation
• Cost reductions primarily driven by reduced
administrative costs and cost synergies
2024 G U I DAN CE
2024 GUIDANCE
Full Year 2024 Guidance
Adjusted EBITDA $505 to $535 million
Adjusted EPS $2.40 to $2.65
Interest Expense $105 to $110 million
Adjusted Effective Tax Rate 23% to 25%
Capital Expenditures ~$140 million
19
Q1 Adjusted EPS of $0.68
AP P E N DI X
21
Performance
Additives
15%
Pigments
TiO2
Dyestuffs
Polyethylene
10%Nylon
Polypropylene
Styrenic Block
Copolymer
Other Raw
Materials
38%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
RAW MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
23%Industrial
Building and
END MARKET REVENUE
$2,007M $358M
$1,138M $224M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$502M$3,143M
(1)
23
(1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs
2023 REVENUE | $2 .0 BILLION
34%
37%
21%
END MARKET REGION
24
34%
21%
15%
Building &
1% Energy
COLOR, ADDITIVES & INKS
2023 REVENUE | $1 .1 BILLION
52%
35%
25
6%Industrial
12%
10% Defense
Building &
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
32%
26%
Building &
6%
2% Defense
1%
(18% of sales)
2023 AVIENT REGIONAL SALES
25%
Building &
(36% of sales)Transportation
22%
Building &
12%
6%
US &
Canada
(41% of sales)
59%
22%
Building &
LATAM
(5% of sales)
26
BY END MARKET
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
Free Cash Flow Calculation December 31, 2023
Cash provided by operating activities $ 201.6
Taxes paid on gain on sale of business 104.1
Adjusted cash provided by operating activities $ 305.7
Capital expenditures $ (119.4)
Free cash flow $ 186.3
Three Months Ended
Year Ended
2023 2022 2023 2022
Sales:
Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0
Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4
Corporate (0.2) (1.2) (2.8) (2.5)
Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9
Operating income:
Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0
Specialty Engineered Materials 29.4 35.2 142.5 140.1
Corporate (48.1) (79.1) (205.6) (197.8)
Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3
Other expense, net: $ 4.3 $ (28.4) $ 5.8 $ (59.7)
Depreciation & amortization:
Color, Additives and Inks $ 22.2 $ 25.2 $ 98.3 $ 101.3
Specialty Engineered Materials 19.8 20.3 81.5 48.7
Corporate 2.2 3.1 9.0 12.5
Depreciation & amortization $ 44.2 $ 48.6 $ 188.8 $ 162.5
Earnings before interest, taxes, depreciation and amortization (EBITDA):
Color, Additives and Inks $ 84.0 $ 69.5 $ 358.2 $ 402.3
Specialty Engineered Materials 49.2 55.5 224.0 188.8
Corporate (45.9) (76.0) (196.6) (185.3)
Other expense, net $ 4.3 $ (28.4) $ 5.8 $ (59.7)
EBITDA $ 91.6 $ 20.6 $ 391.4 $ 346.1
Special items in EBITDA 22.3 86.8 110.4 162.5
EBITDA - excluding special items $ 113.9 $ 107.4 $ 501.8 $ 508.6
APM pro forma adjustments - 8 months 2022* — — — 83.1
Pro forma EBITDA $ 113.9 $ 107.4 $ 501.8 $ 591.7
* Pro forma adjustment for January - August 2022 APM results (period before Avient ownership).
3
AVNT February IR Presentation_w_Non-GAAP Recs.pdf
AVNT February IR Presentation.pdf
Avient corporation�investor presentation
DISCLAIMER
Slide Number 3
Creating a world-class�sustainable organization
Top-tier sustainability performance�and recognition
Slide Number 6
Slide Number 7
Portfolio transformation
Slide Number 9
END MARKET observations�(% of company sales)
Regional observations�(% of company sales)
Slide Number 12
Slide Number 13
Slide Number 14
Slide Number 15
Slide Number 16
Slide Number 17
Slide Number 18
Slide Number 19
Slide Number 20
Slide Number 21
Slide Number 22
2023 segment, end market and Geography
Color, Additives & Inks
Specialty Engineered Materials
Slide Number 26
AVNT Q4 2023 Earnings Presentation.pdf
AVNT Q4 2023 Earnings Presentation_For Website_with Non-GAAP.pdf
IR Deck - AVNT-2023.12.31 (2.12.24 9PM Milestone February 12 0905 pm).pdf
Attachment
3.26.24 - Public Lender Presentation Non-GAAP Attachments (005).pdf
https://www.avient.com/sites/default/files/2025-02/Hexagon and digimat case study.pdf
Digimat for long fibre reinforced
materials
Advanced simulation captures part performance
for fibre reinforced thermoplastics
Comparing the results of isotropic material data to anisotropic
material data
Case study
https://hexagon.com/
Figure 2: Digimat material model workflow when coupled with an FEA solver
Manufacturing Intelligence hexagonmi.com2
Solution
Avient leveraged Digimat to reverse-engineer material
data based on the microstructure, tensile test data,
and micro-mechanical modelling.
Avient and Hexagon used Digimat to develop anisotropic
long fibre material data for a molded connector rod.
We are putting data to work
to boost efficiency, productivity, quality and safety across industrial,
manufacturing, infrastructure, public sector, and mobility applications.
https://www.avient.com/sites/default/files/2021-09/avient-norwalk-a2la-iso17025-17.pdf
0962-01 (1).pdf
https://www.avient.com/sites/default/files/2021-01/avient-luxembourg-sarl-certified-trade-register.pdf
DOC040121-04012021122815.pdf
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=46
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/2023-04/Advanced simulation captures part performance for fibre reinforced thermoplastics_Case_Study.pdf
Digimat for long fibre reinforced
materials
Advanced simulation captures part performance
for fibre reinforced thermoplastics
Comparing the results of isotropic material data to anisotropic
material data
Case study
https://hexagon.com/
Figure 2: Digimat material model workflow when coupled with an FEA solver
Manufacturing Intelligence hexagonmi.com2
Solution
Avient leveraged Digimat to reverse-engineer material
data based on the microstructure, tensile test data,
and micro-mechanical modelling.
Avient and Hexagon used Digimat to develop anisotropic
long fibre material data for a molded connector rod.
We are putting data to work
to boost efficiency, productivity, quality and safety across industrial,
manufacturing, infrastructure, public sector, and mobility applications.
https://www.avient.com/news/avient-showcase-newest-additions-its-healthcare-portfolio-mdm-west-2025
Mevopur colorants can be used for various needs, such as brand recognition and differentiation, drug identification, and visual appeal.
Likewise, Mevopur functional additives can help to protect or enhance the performance of polymers used in medical devices, diagnostics, or pharmaceutical packaging.
The Mevopur product line also includes color and additive concentrates based on polymers with 70%-100% bio-content and pre-tested raw materials which can help to reduce carbon footprint and offer alternatives to fossil-based grades.
https://www.avient.com/resources/safety-data-sheets?page=779
Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe.
Technical Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Jefferies%2520Conference%2520-%25208%253A7%253A2018.pdf
Investor Day
POLYONE
I N V E S T O R
P R E S E N T A T I O N
A U G U S T 2 0 1 8
FORWARD LOOKING STATEMENTS
PolyOne Corporation 2
USE OF
NON-GAAP
MEASURES
PolyOne Corporation 3
V I S I O N
PolyOne Corporation 4
To be the world’s
premier provider of
specialized polymer
materials, services and
solutions
C O R E
V A L U E S
P E R S O N A L
V A L U E S
Honesty IntegrityRespect
Operational
Excellence
Commercial
Excellence
Specialization
Globalization
Collaboration ExcellenceInnovation
To be the world’s
premier provider of
specialized polymer
materials, services
and solutions
S A F E T Y F I R S T
PolyOne Corporation 5
1.3
1.1 1.1
0.85
0.65
0.57
0.54
0.97
0.84
0.74 0.74
0.69
0.57
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
YTD
Injuries per 100 Workers
Spartech
Acquisition
PolyOne Corporation 6
P O L Y O N E
2 0 1 7 R E V E N U E | $ 3 . 2 B I L L I O N
9%
United States
59%
14%
10%
Latin
America
9%
Canada
PolyOne
Distribution
34%
Performance Products &
Solutions 21%
Specialty
Engineered
19%
Color
Additives &
Inks 26%
Segment End Market Geography
Building &
Construction
Electrical &
Electronics
2009 2010 2011 2012 2013 2014 2015 2016* 2017*
P R O O F O F P E R F O R M A N C E
C O N S E C U T I V E
Y E A R S
PolyOne Corporation 7
8
$0.13
$0.68
$0.82
$1.00
$1.31
$1.80
$1.96
$2.06
$2.21
“Where we were” “Where we are”
ROIC** 5.0% 14.0%
Operating Income
% of Sales
Color, Additives & Inks 1.7% 15.5%
Specialty Engineered
Materials
1.1% 12.1%
Performance Products
& Solutions
4.3% 10.7%
Distribution 2.6% 6.3%
A D J U S T E D E P S E X P A N S I O N
S U S T A I N A B L E P A T H T O D O U B L E - D I G I T E P S G R O W T H
PolyOne Corporation 8
P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E
Double digit
annual EPS
growth
strategic acquisitions
Innovate
600K-1M
commercial
resources 6-8%
Double acquired
Lean Six Sigma
commercial excellence
531
689130
157
504
633
2014 Q2 2018
R&D / Technical Marketing Sales
PolyOne Corporation 9
Increased commercial headcount
+ 28%
+ 18%
+ 23%
Generating opportunities
35%
25%
1,000
$1.0B
Enhancing efficiency
I N V E S T M E N T I N COMMERCIAL RESOURCES D R I V I N G G R O W T H
Lead
Specialists
T H E E V O L V I N G C U S T O M E R R E L A T I O N S H I P
PolyOne Corporation 10
Expanded Path
Traditional Path
Strategic Accounts/
Field Sales
Business
Development
Customer
Service
Web and Social
Media
Inside Sales
PolyOne Corporation 11
Investments in digital and dedicated inside sales to
improve customer experience
80% increase in leads (from 6,000 to 11,000) driven
by website, phone, and online chat
EXPANDED PATH
A D D I N G C U S T O M E R T O U C H P O I N T S
4
21
Inside sellers
$11M
$88M
Inside sales/digital revenue
N E W R E S O U R C E S F U E L I N G T H E F U T U R E
PolyOne Corporation 12
P O L Y O N E
S A L E S
F U N N E L
+34%
$3.0 billion
2017
$4.0 billion
A L I G N I N G W I T H T R E N D S F O R G R O W T H
T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R E C O N S U M E R
PolyOne Corporation 13
Facilitate
alternative
energy
solutions
Light-
weighting
Reduce
packaging
materials
Improve
recyclability
Reduce
spread of
infection
I N N O V A T I O N
PolyOne Corporation 14
Customization
55%
M&A
30%
Innovation
Pipeline
Innovation comes from Research & Development Spend
Vitality Index
38%
$20
$52
Transformational
Adjacent
Core
3 H O R I Z O N S O F D E V E L O P M E N T
PolyOne Corporation 15
Market
Technical
I N N O V A T I O N
I N N O V A T I O N P I P E L I N E
PolyOne Corporation 16
PrototypeFrame
Opportunity
Scale-up & Test
Market
Build
Business Case
Commercial
Launch
(since 2015)
Phase 1 Phase 2 Phase 3 Phase 4 Phase 5
8
6
2 1
15 4
10
11
4
7
Breakthrough
Platform
Derivative
F L A M E
R E T A R D A N T
P O L Y M E R S
A D V A N C E D
C O M P O S I T E S
B A R R I E R
M A T E R I A L S
C O L O R A N T
T E C H N O L O G I E S
T H E R M O P L A S T I C
E L A S T O M E R S
I N N O V A T I O N S P O T L I G H T :
C O M P O S I T E S
PolyOne Corporation 17
C O M P O S I T E S R E F R E S H E R
PolyOne Corporation 18
Fiber
Polymer
Composite
S T R A T E G I C I N V E S T M E N T H I S T O R Y
Thermoplastic Composites
Long Fiber Reinforced Thermoplastics
Continuous Fiber Thermosets
Long Fiber Reinforced Thermoplastics
Continuous Fiber Thermosets
2012 2015 20162009 2011 2018
PolyOne Corporation 19
C O M P O S I T E S I N T R A N S P O R T A T I O N
PolyOne Corporation 20
W A T E R C R A F TR A I L H E A V Y T R U C K
PolyOne Corporation 21
Safety Technology Geography Service FinancialPeople
8-10% with
ability to double
I N V E S T - T O - G R O W M & A S T R A T E G Y
PolyOne Corporation 22
Capture
sourcing
synergies
Cross-sell
& blend
technology
8-10%
operating
I N V E S T - T O - G R O W M & A P L A Y B O O K
Protect
customers
Retain
employees
Implement LSS to
drive efficiency
improvements
Innovate with
combined
portfolio
Safety
First!
�) ��$) ��* $�� �&�� &.� �( $* ��/ ��� �8�@
ABBCDAB
EBDABEE
DABEAD
ABEFDAB
EGDABEH
DABEI
ABEJ
K LMN OPQRLS TQRPQOMN OUN OVQWLTXMN QOYXMM TNZ UM XZ[ L
M Q\ Q[ ]^ OLPQRRQOY_ XTL_ Q[̀ LTY
a bcd efa bgh ega bgi eja gi eia kj eca fl eca bjj eda bdd eja bfi eg
m QN OM nLOM UTLLoUNM ]LXTON OVY pXSM LTM Xq
rbk ecsrbj efsri efs tt
tt
tt
u WLPN X[NM LRY pZ LS QTLM Xqv wx
rjl efshj ehrjl ebsgg ebjd eibdj ehlf edhi elih ek
u WLPN X[NM LRY pM XqXỳ UYM RLOM Yv wx
rhf ehsrkd efsrhj efsrbl eksrbi efsrfi efsrgl efsrbg eksrhj els
z̀y UYM L` OLMN OPQRLS TQRPQOMN OUN OVQWLTXMN QOY
XMM TNZ UM XZ[ LM Q\ Q[ ]^ OLPQRRQOY_ XTL_ Q[̀ LTYa bb ela dg eia fd eka lk ega bhd eda bdl ega bfi ega bfj eia blb ed
{N[ UM L` Y_ XTLY
ki ejkd eckj eilk elkd egki egll eflj edlh eb
z̀y UYM L|̀\u XMM TNZ UM XZ[ LM Q\ Q[ ]^ OLPQRRQO
Y_ XTL_ Q[̀ LTY
a c ebia c edla c elha b ecca b eiba b elca b ekda h ecda h ehb
}~� �� ��� ��� ������ ������ ������������ ��� ���� ������ ������� ������� ������ �� ��� ����� ��� ��� ������� �� ������ ��������� ����� ��� �� � ��� ������ ���� ������� ������� ���� �� �� ��������� ��� �� �
���� ���� ���� ���� ��� �� ��� �������� �� ��� �������� ��� ��� ��� �� ���� ��� ������� ����� �� ���� ���� ��� ������ ����������� ��� ���� ������� ����� ��� ���� ���� �� ���� ���� ������ �� ��������� ����� �� ���� ��� ��� ������ ���� ������� ������ ��������� ������������ ������ �������� ��� ���
��������� ��� ���� ���������� ��� ��� ����� ������ ���� � �������� ���������� ����������� �������� ���� ����� ������ �� � ����� �� �� ��� ���� ������� �� �� ���� ��� ���� �� ��� ������ ������������ ����� ��� ������ ����� ������� ������ �� �������� ������� �� ������ ��� ��
���� � ��� ��� �������� ����� ��� �� ��� ���������������� ����� �� ��� �� ������� ����� ���������� ���� ����� ���� ����������� ������ ��������� ��� ������ ����� ������� ��� ��� ������ � �� �� ���� ������� ����� �� ����� ���� ����� ������ �������� ������ ���������� ���� ����
�� ������ �������� ������� ���� �� ��� ������������ �� ��� ����������� ���� ��� ������ ����� ��� ��� ��� ��� ������������ ��� �������� ��� ��� ������������� ���� ����� ����������� �� ���� ��� �� ���� �������� ���� ��������� ���� ��� �� �� ������ ��������� ����� ��� �� ����
��� ������� ���������� �� ������ ���� �������� �� ������ � �¡ ���� ��� ���� �� ��� �� ��� ����� ��� ��������� ������� ������ ��� ��� ������ ���� ��� ��� ���� ������������� �� ������ �� �� �������� �������������� �� ������ ������ ����� ���� ����� �������� ��� ���� � �
8.1.18 Investor Presentation V1.pdf
Non-GAAP Reconciliation - July 2018 (004).pdf
https://www.avient.com/industries/healthcare/medical-packaging
Enhanced packaging for consumer safety and product protection.
Mevopur™ Healthcare Colorants and Formulations
Mevopur™ Healthcare Functional Additives